ArticlebioRxiv : the preprint server for biology2026
Drug-Target Interaction Prediction with PIGLET.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Drug-target interaction (DTI) prediction is a key task for computed-aided drug development that has been widely approached by deep learning models. Despite extremely high reported performance, these models have yet to find widespread success in accelerating real-world drug discovery. In contrast with the most common approach of creating embeddings from one-dimensional or three-dimensional representations of the input drug and input target, we create a novel graph transformer method for DTI prediction that operates on a proteome-wide knowledge graph of binding pocket similarity, protein-protein interactions, drug similarity, and known binding relationships. We benchmark our method, named PIGLET, against existing DTI prediction models on the Human dataset. We assess performance with two different splitting strategies: the frequently-reported random split, and a novel, more rigorous drug-based split. All models perform similarly well on the random split, and PIGLET outperforms all models on the drug-based split. We highlight the utility of PIGLET through a real-world drug discovery case study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.